With this contract dossier whose conditions are established in this specification, it is intended to cover Osakidetza's needs for the use of the drugs included in the dossier for therapeutic indications approved by the competent health authority and which are summarized in the dossier's report.
Centralized contracting of the supply of the drug association of picosulfate (DOE), light magnesium oxide (DOE) and anhydrous citric acid (DOE) powder for oral solution for all Osakidetza service organizations and private and non-profit health centers , located in the Autonomous Community of Euskadi, within the framework provided for in article 30 of Law 8/1997, of June 26, on the Health Organization of Euskadi, which sign a linkage agreement with Osakidetza / Basque Health Service.
Active substance: picosulfate (DOE), light magnesium oxide (DOE) and anhydrous citric acid (DOE)
Amount of active substance: 10 mg / 3.5 g / 10.9 g
Pharmaceutical form: envelopes
Packaging conditions: unit dose
Maximum final price: 2.85 EUR / envelope (Taxes not included)
Number of units planned: 85,000 envelopes (First year of contract)
Maximum estimated budget: EUR 242 250.00 (First year of contract)
Centralized contracting of the supply of the macrogol-based electrolyte solution medicine, 4 envelopes according to detailed composition in the lot for all Osakidetza service organizations and privately owned and non-profit health centers, located in the Autonomous Community of Euskadi, within the framework provided for in article 30 of Law 8/1997, of June 26, on the Health Organization of Euskadi, which sign a relationship agreement with Osakidetza / Basque Health Service.
Active substance: macrogol 3350 (DOE), sodium sulfate (DOE), sodium chloride (DOE), potassium chloride (DOE), ascorbic acid (DOE), sodium ascorbate (DOE)
Amount of active substance:
Each envelope A contains:
Macrogol 3350 100,000 g
Anhydrous sodium sulfate 7,500 g.
Sodium Chloride 2,691 g.
Potassium Chloride 1,015 g.
Each envelope B contains:
Ascorbic acid 4,700 g.
Sodium ascorbate 5,900 g.
Pharmaceutical form: envelopes
Packaging conditions: unit dose
Maximum final price: EUR 6.00 / pack of 4 envelopes (Taxes not included)
Number of units planned: 11,000 packages of 4 envelopes (First year of contract)
Maximum estimated budget 66,000.00 EUR (First year of contract)
Centralized contracting of the supply of the macrogol-based electrolyte solution medicine, 3 envelopes according to detailed composition in the lot for all Osakidetza service organizations and private and non-profit health centers, located in the Autonomous Community of Euskadi, within the framework provided for in article 30 of Law 8/1997, of June 26, on the Health Organization of Euskadi, which sign a relationship agreement with Osakidetza / Basque Health Service.
Active substance: macrogol 3350 (DOE), sodium sulfate (DOE), sodium chloride (DOE), potassium chloride (DOE), ascorbic acid (DOE), sodium ascorbate (DOE)
Amount of active substance:
Dose 1: envelope containing:
Macrogol 3350 100 g
Anhydrous sodium sulfate 9 g
Sodium Chloride 2 g
1 g potassium chloride
Dose 2 (envelopes A and B) contains
About A
Macrogol 3350 40.00 g
Sodium Chloride 3.20 g
Potassium Chloride 1.20 g
About B
Sodium ascorbate
Sodium Ascorbate 48.11 g
Ascorbic acid 7.54 g
Pharmaceutical form: envelopes
Packaging conditions: unit dose
Maximum final price: EUR 6.00 / pack of 3 envelopes (Taxes not included)
Number of units planned: 11,000 packages of 3 envelopes (First year of contract)
Estimated maximum budget: EUR 66,000.00 (First year of contract)
Centralized contracting of the supply of solution for the conservation of organs according to detailed composition in the lot for all Osakidetza service organizations and private and non-profit health centers, located in the Autonomous Community of Euskadi, within the framework provided in Article 30 of Law 8/1997, of June 26, on the Health Organization of Euskadi, which sign a relationship agreement with Osakidetza / Basque Health Service.
Active ingredient: solution for organ conservation
Amount of active substance:
Glutathione 0.921 g (3 mmol)
Mannitol 10,930 g (60 mmol)
Lactobionic acid 28.664 g (80 mmol)
Glutamic acid 2,942 g (20 mmol)
Sodium hydroxide 4,000 g (100 mmol)
Calcium chloride dihydrate 0.037 g (0.25 mmol)
Potassium chloride 1,118 g (15 mmol)
Magnesium chloride hexahydrate 2,642 g (13 mmol)
Histidine 4,650 g (30 mmol)
Pharmaceutical form: 1 liter bag
Packaging conditions: unit dose
Maximum final price: EUR 625.00 / pack of 4 1-liter bags (Taxes not included)
Number of units planned: 400 packages of 4 bags of 1 liter (First year of contract)
Estimated maximum budget: EUR 250,000.00 (First year of contract)